Australasian Bronchiolitis Guideline: 2023 Update
- MeSH Terms
Bronchiolitis (C01.748.099.135; C08.127.446.135; C08.381.495.146.135; C08.730.099.135); diagnostic techniques and procedures (E01.370); clinical laboratory techniques (E05.200); patient discharge (E02.760.400.610); therapeutics (E02); respiration, artificial (E02.041.625); feeding methods (E02.421); physical therapy modalities (E02.779); respiratory therapy (E02.880); drug therapy (E02.319); drainage (E02.309); antibodies, monoclonal, humanized (D12.776.124.486.485.114.224.060); immunization (E02.095.465.425.400); covid-19 (C01.748.610.763.500); intensive care, neonatal (E02.760.190.405); hospitalization (E02.760.400); infant (M01.060.703)
- Guideline Contact
- Stuart Dalziel (s.dalziel@auckland.ac.nz); Meredith Borland (meredith.borland@health.wa.gov.au)
- English Title Translation
- N/A
- Keywords
- Bronchiolitis; diagnosis; intervention; prevention; cost-effectiveness
- Date for Review
- 01/06/2029
- Publication Date
- 01/06/2018
- Expected Publication Date
- 01/02/2025
- Date of Last Evidence Search
- 21/06/2023
- Methods Applied
- Systematic review; GRADE; risk of bias; meta-analysis
- Publication Scope
- assessment
- Diagnosis, Treatment
- management
- prevention
- Countries of Application
- Australia
- New Zealand
- Guideline Publication Status
- Development
- Languages
- English
- Authors
- PREDICT (AUS/NZ)
- Willingness to Collaborate
- No